who should not use glp-1 America's Most Talked-About Drug Has a Surprising Secret: 69% of Users Are Unlikely to Admit Taking It Who Should Not Take GLP-1

This generates a proton gradient that powers ATP synthase to produce ATP

Investigation into GLP-1-based diabetes therapies concluded

Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding

Some of the ways we help you lose weight include exercise and behavioral modification

Among dual agonists, tirzepatide at 15 mg weekly (Zepbound) produced 20% to 22% mean weight loss

This head-to-head randomized trial directly compared tirzepatide with semaglutide for obesity treatment and provides high-level evidence for the magnitude of weight loss achievable with current incretin-based pharmacotherapy